IGI Q2 FY27 slides: certification revenue surges 32%, EBITDA up 39%

International Gemological Institute reported Q2 FY27 certification revenue of INR 3,875 million, up 32% year on year, while EBITDA rose 39% to INR 2,445 million and profit after tax increased 43% to INR 1,858 million. For H1 FY27, certification revenue grew 27% to INR 7,474 million and EBITDA rose 34% to INR 4,683 million. Management expects to outperform its original full-year guidance of 15% revenue growth and 20% EBITDA growth; the article also cites projected 17–19% CAGR in global certification volumes through 2030.

Analysis

The investable mechanism is certification volume growth with operating leverage, but the quality of that growth matters more than the headline CAGR. If lab-grown diamond (LGD) volumes keep rising, IGI can benefit as a high-fixed-cost tollbooth without taking direct exposure to stone inventory or wholesale prices. However, LGD price stabilization does not prove durable certification pricing power: continued production expansion could make stones more interchangeable, pressure retailer economics, and eventually shift bargaining power toward large manufacturers and retailers. That would let volumes grow while limiting realized fees per report.

The clearest near-term check is standalone India margin compression despite strong growth. Consolidated margin expansion may partly reflect mix and the AGL acquisition; it should not be extrapolated until organic margins and acquisition contribution are separated. In the next 1–3 months, verify guidance delivery, fee realization per report, and whether hiring, commissions, and marketing costs continue to rise. Over 6–18 months, U.S. expansion offers upside, but incumbent trust, retailer adoption, and local operating costs may slow conversion of the market opportunity into earnings. GIA and HRD Antwerp are relevant competitive alternatives; broader acceptance of multiple certifiers would constrain pricing.

There is a material source-integrity problem: the headline refers to SpaceX/Tesla, while the body concerns IGI; the supplied company-identity mapping is empty; and the text contains inconsistent reporting dates and a share price/currency context that cannot be reconciled from the provided material. Do not trade the quoted price or infer a ticker until the security and figures are independently verified. The bullish operating thesis is conditional, not a verified security recommendation.

Key Decisions for Investors

• No immediate position on the supplied quote. First confirm the issuer, exchange, share class, currency, reporting periods, and original filing; the headline/body mismatch and date inconsistencies are sufficient to invalidate price-based execution.
• If identity and results are confirmed, consider a staged long only after the next reported quarter supports fee realization and organic EBITDA growth—not just report-volume growth. Falsify the thesis if realized price per report weakens materially or organic EBITDA growth falls below revenue growth.
• Track standalone India EBITDA margin and separate organic performance from AGL contribution. Persistent compression beyond the stated investment phase would challenge the assumption that incremental certification volume carries attractive operating leverage.
• Set a 1–3 month catalyst watch around full-year guidance and U.S. expansion evidence: retailer/customer wins, local certification volumes, and any change in investment or operating costs. Do not underwrite the addressable-market estimate as earnings without those conversion metrics.
• Monitor LGD wholesale prices and producer capacity over 6–18 months. Renewed price declines alongside continued capacity growth could support near-term certification volumes but also signal commoditization and weaker long-run fee power; that combination would argue against paying a growth multiple.